• Laminin (925-933): A Translational Cell-Migration Tool

  2026-08-18

  Laminin (925-933) is a defined Laminin B1 chain peptide for mechanistic studies of cell adhesion, migration, chemotaxis, and extracellular matrix signaling. This thought-leadership guide connects receptor-focused assay design with translational questions in oncology and neuroscience while clarifying the evidence boundaries around metastasis and Alzheimer’s disease research.

• Short-Scale BIR and DNA Damage in Mouse Oocytes

  2026-08-18

  The reference study identifies short-scale break-induced replication in fully grown mouse oocytes and shows that DNA double-strand breaks can be amplified through Rad51-dependent or replication-associated processes. Its combined use of EdU, cH2A.X, pathway inhibitors, aphidicolin, and ddATP provides a practical framework for distinguishing DNA synthesis from damage amplification.

• GlycoRNA–RBP Surface Domains and TAT Entry

  2026-08-17

  A bioRxiv study presents evidence that cell-surface RNA-binding proteins and glycoRNAs organize into RNA-sensitive nanoclusters that support entry of the cell-penetrating peptide TAT. The work broadens the concept of the plasma membrane and suggests experimental strategies for distinguishing surface-accessible protein assemblies from conventional transmembrane receptors.

• Merbromin as a Tissue-Marking Dye in Biopsy Processing

  2026-08-17

  A 2023 study evaluated Merbromin and four other dyes as visibility aids for very small tissue specimens during routine histopathology processing. Merbromin, hematoxylin, and alcian blue improved tissue observability, but hematoxylin offered the best balance of visibility, lower toxicity, and minimal interference with diagnostic slide examination.

• Nifedipine: Calcium Control in Liver Assays

  2026-08-16

  Nifedipine (BAY-a-1040) is more than a calcium channel blocker: it can serve as a controlled perturbation in assays connecting calcium influx inhibition with hepatic metabolic adaptation. This guide explains how to pair B1988 with PXR-focused liver models without confusing calcium effects with direct transcriptional activation.

• VE-822 ATR Inhibitor: PDAC Research Workflow

  2026-08-15

  VE-822 is a potent ATR inhibitor for testing replication-stress biology and pairing DNA damage response inhibition with radiation or gemcitabine in pancreatic cancer models. This workflow combines practical dosing, assay controls, iPSC-inspired prescreening logic, and troubleshooting for more interpretable chemoradiotherapy experiments.

• Brassinolide: Cross-Domain Research Workflows

  2026-08-15

  Brassinolide supports complementary workflows spanning plant root-growth assays, PC-3 apoptosis studies, and exploratory diabetes research. This guide translates mechanistic evidence into practical formulation, experimental-design, and troubleshooting strategies while separating validated findings from optimization recommendations.

• Halazone and Sodium Current Inactivation in Frog Nerves

  2026-08-14

  The reference study used chemical perturbation of voltage-clamped frog nerve fibers to show that Halazone and hypochlorous acid strongly disrupt sodium-current inactivation, whereas several other oxidants produce different effects. Its comparative design challenges a simple methionine-centered explanation and points instead toward a possible role for membrane lipids in inactivation kinetics.

• HNRNPU K181 Lactylation Rewires Serine Metabolism

  2026-08-14

  This Advanced Science study identifies HNRNPU lysine 181 lactylation as a lactate-responsive switch that stabilizes HNRNPU, increases PHGDH mRNA regulation, and promotes serine biosynthesis in cervical cancer. The work connects a non-histone post-translational modification to metabolic rewiring and evaluates pharmacological interference with this axis while highlighting important questions about specificity and transferability.

• ApexPrep DNA Plasmid Miniprep Kit for AML Assays

  2026-08-13

  Build reproducible plasmid workflows for cloning, sequencing, and AML functional assays with a single alkaline-lysis platform. The ApexPrep DNA Plasmid Miniprep Kit supports high- and low-copy constructs while providing practical troubleshooting guidance for molecular biology grade plasmid DNA.

• Uremic Metabolite Adsorption on Hydroxy-PEO Films

  2026-08-13

  The 2025 study shows that hydroxy-terminated polyethylene oxide films do not interact uniformly with uremic metabolites: adsorption depends on chain density, exposure time, and metabolite structure. Its multi-component design moves low-fouling biomaterial research closer to the chemical complexity of kidney failure blood and provides a framework for testing metabolite-specific surface interactions.

• Ibrexafungerp (MK 3118): Mechanism and Evidence

  2026-08-12

  Ibrexafungerp, also called MK 3118, is an oral triterpenoid antifungal that inhibits fungal 1,3-β-D-glucan synthase. Evidence supports activity against resistant Candida, including Candida auris, while clinical approval currently centers on vulvovaginal candidiasis and recurrent VVC prevention.

• Diuron-Induced Acute Renal Injury: JAK2/STAT1

  2026-08-12

  The reference study integrates network toxicology, transcriptomic validation, molecular docking, and HK-2 cell experiments to investigate how Diuron may cause acute kidney injury. Its central finding is that JAK2/STAT1 signaling is associated with Diuron-induced renal toxicity, providing a mechanistic framework for environmental exposure assessment while highlighting the need for further validation in physiologically relevant models.

• MEK/ERK Control of TERT in Human Stem Cells

  2026-08-11

  This preprint identifies a signaling–epigenetic mechanism that sustains TERT transcription in human pluripotent stem cells: MEK1/2–ERK1/2 activity and c-Myc:MAX cooperate to oppose PRC2-associated repression at the TERT promoter. The findings connect MAPK signaling to telomere maintenance and provide a framework for interpreting ERK-pathway perturbation in stem-cell and cancer research.

• AmpC/AmpD Resistance to Ceftolozane-Tazobactam

  2026-08-10

  Deroche and colleagues combined allelic reconstruction, sequential time-kill experiments, and semi-mechanistic PK/PD modeling to separate the immediate and adaptive effects of AmpC and AmpD mutations on ceftolozane-tazobactam activity. The work shows why endpoint susceptibility alone may underestimate resistance dynamics and provides a framework for interpreting treatment-emergent resistance in clinical Pseudomonas aeruginosa isolates.

444 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page